Open‐Label, Crossover Study to Determine the Pharmacokinetics of Fluticasone Furoate and Batefenterol When Administered Alone, in Combination, or Concurrently

The study aim was to investigate the pharmacokinetics of single high doses and repeated therapeutic doses of fluticasone furoate (FF) and batefenterol (BAT; a bifunctional muscarinic antagonist and β(2)‐agonist) administered in combination (BAT/FF) or as monotherapy. In this open‐label, 6‐period, cr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ambery, Claire, Young, Graeme, Fuller, Teresa, Georgiou, Alex, Ramsay, David, Puri, Adeep, Daley‐Yates, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585707/
https://www.ncbi.nlm.nih.gov/pubmed/30070770
http://dx.doi.org/10.1002/cpdd.603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585707/
https://www.ncbi.nlm.nih.gov/pubmed/30070770
http://dx.doi.org/10.1002/cpdd.603

Ejemplares similares